Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV vaccine trials]

K Ikuta1

  • 1Section of Serology, Hokkaido University.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

A novel recombinant BCG vaccine expressing an HIV gp120 epitope rapidly induced HIV-specific cytotoxic T lymphocytes (CTLs) in mice. This approach offers a potential new strategy for developing effective HIV vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KLF15 deficiency accelerates cartilage destruction in inflammatory arthritis.

Scandinavian journal of rheumatology·2026
Same author

Donors in the COVID-19 era: How did donor characteristics change in Japan?

Vox sanguinis·2025
Same author

A resonant sextuplet of sub-Neptunes transiting the bright star HD 110067.

Nature·2023
Same author

Geriatric nutritional risk index as the prognostic factor in older patients with fragility hip fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

In Vitro Maturation and In Vivo Integration and Function of an Engineered Cell-Seeded Disc-like Angle Ply Structure (DAPS) for Total Disc Arthroplasty.

Scientific reports·2017
Same author

Characterization of two anti-dengue human monoclonal antibodies prepared from PBMCs of patients with dengue illness in Thailand.

Acta virologica·2016
Same journal

[The clinical condition and treatment of diseases associated with sudden death].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[The new era of anemia in the elderly].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[Lifestyle and health: results from epidemiological studies].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[Clinical significance of awake neurosurgery].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[Current understanding of the mechanism of undesirable transfusion reaction and the preventive strategires against them].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
Same journal

[AMED: Missions and Challenges].

[Hokkaido igaku zasshi] The Hokkaido journal of medical science·2016
See all related articles

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Context:

  • Significant progress in HIV vaccine development includes live recombinant virus, inactivated virus, and subunit vaccines.
  • Phase I and II trials have focused on inducing neutralizing antibodies and cytotoxic T lymphocytes (CTLs) against HIV Env proteins.
  • Cell-mediated immunity is crucial for controlling HIV spread and preventing AIDS.

Purpose:

  • To develop a novel recombinant BCG (rBCG) vaccine expressing an immunodominant epitope of HIV gp120.
  • To assess the immunogenicity of the rBCG vaccine in inducing HIV-specific immune responses.

Summary:

  • A recombinant BCG vaccine was engineered to express an immunodominant epitope from the HIV gp120 V3-loop, fused to an extracellular antigen of Mycobacterium kansasii.

Related Experiment Videos

  • Balb/c mice vaccinated with this rBCG rapidly developed HIV-specific CTLs.
  • The induced CTLs demonstrated target cell lysis restricted to the H-2d MHC class I.

    • Impact:

    • This study introduces a promising rBCG-based vaccine strategy for HIV prevention.
    • The findings highlight the potential of using BCG as a vector for delivering HIV antigens.
    • Further research could lead to a safe and effective prophylactic vaccine against HIV infection.